Clinical trial
PREDICT: A Prospective, Multicenter Real-World Study to Describe the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
NCT07446738 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PREDICT: A Prospective, Multicenter Real-World Study to Describe the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 19, 2026
- Completion date
- October 21, 2027
- Enrollment
- 146 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
chronic rhinosinusitis with nasal polyps